Biomaterials are materials derived from synthetic or natural materials. They are used in medical implants to increase the body functionality of a particular organ. Biomaterials have applications in Cardiovascular, Ophthalmology, Dental, Orthopedic, Wound Healing, Tissue Engineering, Plastic Surgery, Neurology, and others. Common biomaterials include heart valves, stents, artificial knee, and hip joints. Biomaterials replace hard or soft tissues that cannot function due to damage or destruction through some pathological process.
Rising Prevalence of Musculoskeletal and Chronic Skeletal Medical Conditions
According to the World Health Organization (WHO), musculoskeletal conditions are the leading cause of disability. Common musculoskeletal conditions such as trauma, back pain, and arthritis affect mobility, which leads to early retirement. These chronic conditions can occur at age and are more prevalent in the low-income group.
The Global Burden of Disease Study 2017 reported that the prevalence of a painful musculoskeletal condition is between 20–33% global population. Treatment of these conditions, such as joint replacement, orthobiologics, tissue fixation, and viscosupplementation, is carried out using biomaterials.
Escalating Prevalence of Ophthalmic Diseases Coupled with Rising Aged Population
The rising occurrence of ophthalmic disorders contributes considerably to the biomaterials market. Corneal blindness is the third leading cause of blindness, followed by glaucoma and cataract, affecting 10 million people worldwide. Globally, about 200,000 corneal implant procedures are performed every year, and about 12.7 million patients are waiting for their corneal implants.
According to the Royal National Institute of Blind People (RNIB), around 2 million people were living with sight loss in the U.K. in 2013 and is anticipated to surge by 4.1 million by 2050. Astigmatism happens in approximately 1 out of every 3 persons in the U.S., according to the Eye Disease statistics in America 2020. Farsightedness arises in about 8.4% of the population, and nearsightedness approximately 23.9% of the over 40-year-old population. The statistical figures project the surge in demand for biomaterials during the forecast period.
The geriatric population has a higher susceptibility to developing ophthalmic diseases. The older population is vulnerable to numerous chronic diseases, such as diabetes, which may lead to several eye-related diseases, such as superficial punctate keratitis, persistent epithelial defects, endothelial corneal injury, and periodic corneal erosion.
As per the World Health Organization, in 2014, there were 285 million visually-disabled people across the globe, 246 of whom had poor vision and 39 million were fully blind and 82% of those living with blindness were aged 50 and above. Diabetic diseases are annually responsible for 12,000 to 24,000 cases of blindness in the U.S., according to the NCBI survey. The growing prevalence would lead to increased hospitalization, which will lead to a rise in ophthalmology statistics, eventually pushing demand growth.
Based on type, the market is segmented into metallic, polymeric, ceramic, and natural. Metallic biomaterials made of stainless steel, titanium and titanium alloys, cobalt-chrome alloys, gold, silver are mainly used to provide internal support for joint replacements, dental implants, orthopedic fixations, and stents.
Polymeric materials such as polymethylmethacrylate (PMMA), polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, and polyetheretherketone are used within physiological environments as a replacement for various tissues. Ceramic biomaterials have unique properties of hardness and resistant to abrasion. They can be easily inserted without any side-effects within the human body, making them useful in bones and teeth replacement.
Naturally derived biomaterials are made from proteins, polysaccharides, decellularized tissues. Factors such as non-toxic, non-carcinogenic and non-immunogenic, and biocompatibility are expected to make the polymeric segment the fastest-growing segment.
Based on application, the biomaterials market is dominant in cardiovascular and orthopedic applications. The introduction of advanced orthopedic implants by biomaterials manufacturers increased the demand for biomaterials in orthopedic applications.
The plastic surgery segment is expected to dominate the market during the forecast period owing to the rising demand for cosmetic procedures. According to the American Society of Plastic Surgeons, around 18.1 million cosmetic surgeries were performed In the U.S. in 2019, which includes 1.8 million cosmetic surgical procedures and 16.3 million cosmetic minimally-invasive procedures, fueling the global biomaterials market growth.
North America is expected to hold the largest market share in terms of revenue during the forecast period. Technological advancement and product innovation has led to an increase in the healthcare infrastructure over the years. Investment by public and private players, government policies, and the presence of major market players are expected to significantly contribute to the market growth. Initiatives taken by the National Science Foundation and National Institute of Standards and Technology are constantly in the mix of research and development in biomaterial science and are an integral part of market growth.
Europe has also emerged as a dominant region for the biomaterials market. Organizations like the European Society for Biomaterials have been focusing on tackling unmet clinical needs through regenerative medicine involving biomaterials. Other factors contributing to the regional market growthinclude rising geriatric population, strong impetus on healthcare initiatives by the European Commission, and increasing chronic conditions.
The EU has provided grants and invested in mental health, which is expected to bolster market growth in neurological application. Countries such as Germany, France, and Sweden hold dominant shares in the region according to Eurostat 2017, while countries such as Romania, Bulgaria, and the Baltic member states are expected to grow at a high rate during the forecast period.
The growing healthcare market in the emerging economies, such as Brazil, India, Russia, and China, is expected to drive the market during the forecast period. Large population, increasing disposable income, rising adoption of implants, and growth of its related infrastructure contribute to the market growth. Government funding for healthcare is also on the rise in developing countries, which is also expected to drive market growth during the forecast period.
Royal DSM, BASF SE, Corbion, Carpenter Technology Corporation, Evonik Industries, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., Celanese Corporation, CoorsTek Inc., CeramTec, and GELITA AG
Biomaterials Market: Segmentation
Frequently Asked Questions (FAQs)